Skyscape Web Viewer : EBMG : Cardiovascular Disease and Vascular Diseases : Secondary Index

View All
Cyclooxygenase 2 Inhibitors
Cyclophosphamide
Cyclosporine
Cysticercosis
Cystic Fibrosis
Cystitis
Cystoscopy
Cystostomy
Cysts
Cyst
Cytology
Cytomegalovirus
Cytostatic Agents
Cytotoxic chemotherapy Adjuvant Therapy of Node-Negative Breast Cancer Chemotherapy for Advanced Endometrial Carcinoma
D06
D175N
D50
Dabigatran
Dactylitis
Dairy Products
Dalteparin Achilles Tendinopathy and Tendon Rupture Acute Coronary Syndrome Anticoagulation for the Intial Treatment of Venous Thromboembolism in Patients with Cancer Antithrombotic Agents in Primary Health Care Deep Vein Thrombosis Extended DVT Prophylaxis after Hospital Discharge in Patients with Elective Hip Arthroplasty Low-Molecular Weight Heparin in Patients with Acute Myocardial Infarction Treated with Thrombolytic Therapy Low Molecular Weight Heparins for Acute Coronary Syndromes Once Versus Twice Daily Low Molecular Weight Heparin for the Initial Treatment of Venous Thromboembolism Parenteral Anticoagulation in Ambulatory Patients with Cancer Prevention of Venous Thromboembolism Pulmonary Embolism Treatment of Deep Venous Thrombosis
Danaparoid Antithrombotic Agents in Primary Health Care Low-Molecular-Weight Heparins Vs. Standard Heparin for Acute Ischaemic Stroke
Danazol
Dantrolene Anti-Spasticity Agents for Multiple Sclerosis Pharmacological and Nutritional Treatment for Mcardle Disease (Glycogen Storage Disease Type V)
Dapsone
Darbepoetin
Daunorubicin
Day surgery
Daytime fatigue
DCD